Eris Lifesciences Future Growth
Future criteria checks 4/6
Eris Lifesciences is forecast to grow earnings and revenue by 16.3% and 20.5% per annum respectively. EPS is expected to grow by 16.4% per annum. Return on equity is forecast to be 20.3% in 3 years.
Key information
16.3%
Earnings growth rate
16.4%
EPS growth rate
Pharmaceuticals earnings growth | 18.7% |
Revenue growth rate | 20.5% |
Future return on equity | 20.3% |
Analyst coverage | Good |
Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 35,348 | 7,452 | 8,955 | N/A | 2 |
3/31/2026 | 30,415 | 5,592 | 6,585 | N/A | 7 |
3/31/2025 | 26,487 | 4,378 | 5,593 | N/A | 8 |
3/31/2024 | 19,706 | 4,096 | -336 | N/A | 7 |
12/31/2023 | 18,406 | 3,864 | N/A | N/A | N/A |
9/30/2023 | 17,750 | 3,856 | -3,302 | 4,446 | N/A |
6/30/2023 | 17,298 | 3,824 | N/A | N/A | N/A |
3/31/2023 | 16,618 | 3,822 | -5,497 | 2,917 | N/A |
12/31/2022 | 15,663 | 3,970 | N/A | N/A | N/A |
9/30/2022 | 14,766 | 3,959 | 419 | 2,844 | N/A |
6/30/2022 | 13,746 | 3,940 | N/A | N/A | N/A |
3/31/2022 | 13,262 | 4,061 | 2,572 | 3,783 | N/A |
12/31/2021 | 12,993 | 3,941 | N/A | N/A | N/A |
9/30/2021 | 12,763 | 3,834 | 4,058 | 4,428 | N/A |
6/30/2021 | 12,482 | 3,728 | N/A | N/A | N/A |
3/31/2021 | 11,926 | 3,551 | 3,496 | 3,754 | N/A |
12/31/2020 | 11,625 | 3,432 | N/A | N/A | N/A |
9/30/2020 | 11,192 | 3,165 | 1,211 | 2,724 | N/A |
6/30/2020 | 10,744 | 3,015 | N/A | N/A | N/A |
3/31/2020 | 10,582 | 2,965 | 1,199 | 2,712 | N/A |
12/31/2019 | 10,252 | 2,943 | N/A | N/A | N/A |
9/30/2019 | 10,119 | 3,110 | 2,219 | 2,599 | N/A |
6/30/2019 | 9,920 | 3,036 | N/A | N/A | N/A |
3/31/2019 | 9,672 | 2,908 | 1,850 | 2,230 | N/A |
12/31/2018 | 9,851 | 2,925 | N/A | N/A | N/A |
9/30/2018 | 9,442 | 2,870 | N/A | N/A | N/A |
6/30/2018 | 9,212 | 2,945 | N/A | N/A | N/A |
3/31/2018 | 8,196 | 2,941 | 2,095 | 2,346 | N/A |
12/31/2017 | 8,026 | 2,800 | N/A | N/A | N/A |
9/30/2017 | 7,781 | 2,735 | N/A | N/A | N/A |
6/30/2017 | 7,277 | 2,505 | N/A | N/A | N/A |
3/31/2017 | 7,205 | 2,468 | N/A | 2,002 | N/A |
3/31/2016 | 5,967 | 1,112 | N/A | 1,315 | N/A |
3/31/2015 | 5,456 | 892 | N/A | 901 | N/A |
3/31/2014 | 5,088 | 704 | N/A | 896 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 540596's forecast earnings growth (16.3% per year) is above the savings rate (6.7%).
Earnings vs Market: 540596's earnings (16.3% per year) are forecast to grow slower than the Indian market (17.7% per year).
High Growth Earnings: 540596's earnings are forecast to grow, but not significantly.
Revenue vs Market: 540596's revenue (20.5% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: 540596's revenue (20.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 540596's Return on Equity is forecast to be high in 3 years time (20.3%)